Newsroom

WALTHAM, Mass.--(BUSINESS WIRE)--Korsana Biosciences, Inc. (“Korsana” or the “Company”), a biotechnology company discovering and developing novel therapies to reduce the burden of neurodegenerative diseases, today announced the appointments of Matthew Leoni, M.D., as Chief Medical Officer, Gan Wei, Ph.D., as Chief Technical Officer, and Heidi Henson as a member of its Board of Directors, where she will serve as Chair of the Audit Committee. Collectively, these appointments strengthen Korsana's...

RICHMOND, Va.--(BUSINESS WIRE)--Capital Square, a leading sponsor of tax-advantaged real estate investments and an active developer and manager of housing communities nationwide, today announced the launch of CS1031 Colony at Centerpointe Apartments, DST, a Delaware statutory trust offering ownership interests in a 255-unit, Class A-, garden-style apartment community located in the Richmond suburb of Midlothian, Virginia. The offering seeks to raise $42.95 million in equity from accredited inves...

NEW YORK & LONDON--(BUSINESS WIRE)--KKR, a leading global investment firm, today announced the final closing of KKR Global Infrastructure Investors V (“Fund V” or the “Fund”), a $19.2 billion Core+ fund focused on investing in critical infrastructure assets and businesses primarily in North America and Western Europe. Fund V, the fifth vintage in KKR’s Global Infrastructure Strategy, is KKR’s largest infrastructure fund raised to date. Fund V contributes to approximately $45 billion raised acro...

OLD GREENWICH, Conn.--(BUSINESS WIRE)--Ellington Credit Company (NYSE: EARN) (the "Company") today announced that it will release financial results for the quarter ended June 30, 2026 after market close on Wednesday, August 12, 2026. The Company will host a conference call to discuss its financial results at 11:00 a.m. Eastern Time on Thursday, August 13, 2026. To participate in the event by telephone, please dial (800) 343-4849 at least 10 minutes prior to the start time and reference the conf...

PROVIDENCE, R.I.--(BUSINESS WIRE)--Bally's Corporation (NYSE: BALY) today announced the successful closing of its acquisition of Sam's Town Shreveport from Boyd Gaming, marking another milestone in the company's continued investment in Louisiana and expansion of its regional gaming and entertainment portfolio.The transaction adds an established gaming and hospitality property to Bally's growing portfolio and further reinforces the company's long-term commitment to the Shreveport-Bossier market....

BRYN MAWR, Pa.--(BUSINESS WIRE)--Essential Utilities Inc. (NYSE: WTRG), one of the nation’s largest publicly traded providers of water, wastewater and natural gas services, proudly recognizes Water Quality Month this August. Established by the U.S. Environmental Protection Agency in 2005, the annual observance highlights the vital importance of clean, safe water to public health, thriving communities and a sustainable environment. “Water is one of our planet’s most vital natural resources, and...

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to zocilurtatug pelitecan (zoci, formerly ZL-1310), the Company’s potential first-in-class Delta-like ligand 3 (DLL3) antibody-drug conjugate (ADC), for the treatment of neuroendocrine carcinomas (NECs). NECs are aggressive malignancies that frequently express DLL3. There are no available targeted therapies...

BOSTON--(BUSINESS WIRE)--Seaport Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress...

CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (Rocket or the Company) (NASDAQ: RCKT), a fully integrated, commercial-stage biotechnology company advancing genetic medicines for rare and devastating diseases, focused on inherited cardiovascular disorders, today announced a positive clinical safety update regarding the initial three patients treated under the modified protocol for its global, pivotal Phase 2 trial of RP-A501 in Danon disease. Early safety has been promising with t...

PALO ALTO, Calif. & NEW YORK--(BUSINESS WIRE)--D-Wave Quantum Inc. (NASDAQ: QBTS), (“D-Wave” or the “Company”), the only dual-platform quantum computing company providing both annealing and gate-model systems, software and services, and Nasdaq Verafin announced today an agreement designed to evaluate the use of quantum computing to improve financial crime detection. The collaboration will begin with the development of a proof-of-concept (PoC), with the potential to expand to pilot applications...